News and Insights of 3D Printing and Manufacturing
As additive manufacturing gradually improves its viability as a manufacturing process, its role as a prototyping technology can sometimes be overlooked or underemphasized. Rather than seeing its prototyping potential as a limitation, however, there are some who are looking to shine a spotlight onto this particular application of 3D printing.
Stryker’s Spine division today announced the publication of a pre-clinical animal study comparing the performance of spinal implants made from a variety of materials, which illustrated the bone ingrowth and biological fixation capabilities of its 3D-printed Tritanium cages. The study, titled “Bony Ingrowth Potential of 3D Printed Porous Titanium Alloy: A Direct Comparison of Interbody Cage Materials in an In Vivo Ovine Lumbar Fusion Model,” was published in the July issue of The Spine Journal.
CELLINK, the Swedish startup that created one of the first universal bioinks and manufacturers cost effective bioprinters, is working on a EU co-funded project called TumorPrint. The project aims to develop and commercialize a Specific Bioprinting platform, including bioinks, software and hardware, specialized for printing of human cancer tumors.
Besides colliding hadrons to unravel the misteries of the Universe, CERN technology is at the heart of many things that have become widespread today, from CD’s to the Internet to the Cloud. They of course use 3D printers at CERN (although not subatomic ones) ad this time New Zealand based MARS Bioimaging used a CERN technology to produce a machine capable of creating the first color X-ray 3D scan of a human.
Chicago-based biotech company BIOLIFE4D announced this week that it has successfully 3D bioprinted a human cardiac tissue patch, bringing the company a small step closer to its ultimate goal of 3D bioprinting a viable and transplantable human heart.
As per a new partnership agreement, Shanghai-based 3D printing company INTAMSYS will be collaborating with the Department of Orthopaedic Surgery at the University of California, San Francisco (UCSF) to further advance additive manufacturing applications for orthopaedic surgery and, specifically, applications for PEEK and other high-performance materials.
Antibacterial materials and filaments for 3D printing, something that many consider being a key development for biomedical 3D printing applications – are now widely available through a series of new materials introduced by Santhiago, Chile-based startup Copper3D.
Poietis, a leading French bioprinting company and Prometheus, the Division of Skeletal Tissue Engineering at KU Leuven, entered into a 2-years Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration.
Additive manufacturing pioneer 3D Systems has introduced its new On Demand Anatomical Modeling Service for medical 3D printing applications. The newly launched service provides medical professionals access to 3D printable and highly detailed anatomical models for improving surgical planning as well as patient education.
With increasing life expectancies across much of the globe, the need for medication and treatments for age-related degenerative muscle and tendon diseases is growing. And though much research is being done on that front, medical scientists have faced consistent challenges in developing effective drugs for muscle degeneration. Fortunately, a team of researchers in Switzerland is conducting microplate bioprinting research that could offer a solution to one of the main challenges in developing treatments.